Pfizer weighs working with BioNTech on potential coronavirus vaccine - R&D head

Pfizer Chief Scientific Officer Mikael Dolsten was one of the pharmaceutical executives who attended a meeting with U.S. President Donald Trump to discuss possible vaccines and treatments for the fast-spreading virus on Monday. Dolsten said that Pfizer, which already collaborates with BioNTech on the development of mRNA-based vaccines for influenza, is also interested in the company's efforts in coronavirus.

from Yahoo Finance https://ift.tt/3cz4yYx